WallStSmart
BRTX

BioRestorative Therapies Inc

NASDAQ: BRTX · HEALTHCARE · BIOTECHNOLOGY

$0.23
+11.60% today

Updated 2026-04-30

Market cap
$5.86M
P/E ratio
P/S ratio
16.28x
EPS (TTM)
$-1.58
Dividend yield
52W range
$0 – $2
Volume
10.4M

BioRestorative Therapies Inc (BRTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
-12.0%
Last 4 quarters
Revenue YoY growth
-54.7%
Most recent quarter
EPS YoY growth
+14.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-7.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-11.3%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.32+5.9%$0.31$0.30-4.1%
2025-11-12$-0.33+13.2%$1.41$1.25-11.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.34$-0.32+5.9%$19600.00-54.7%
2025-09-30$-0.38$-0.33+13.2%$11800.00-94.9%
2025-06-30$-0.38$-0.30+21.1%$303300.00+240.4%
2025-03-31$-0.34$-0.64-88.2%$25000.00-28.6%
2024-12-31$-0.55$-0.38+32.2%$43300.00+124.4%
2024-09-30$-0.43$-0.01+98.4%$233600.00+660.9%
2024-06-30$-0.56$-0.50+10.7%$89100.00+38.1%
2024-03-31$-0.52$-0.33+36.5%$35000.00+11.8%
2023-12-31$-0.69$-0.57+17.4%$19300.00
2023-09-30$-0.68$-0.65+4.4%$30700.00
2023-06-30$-1.19$-0.77+35.3%$64500.00
2023-03-31$-1.26$-1.53-21.4%$31300.00

Frequently asked questions

Has BioRestorative Therapies Inc beaten earnings estimates?
BioRestorative Therapies Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of -12.0% over the last 4 quarters.
How does BRTX stock react to earnings?
BRTX stock has moved an average of -7.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is BioRestorative Therapies Inc's revenue growth rate?
BioRestorative Therapies Inc reported year-over-year revenue growth of -54.7% in its most recent quarter, with EPS growing +14.7% year-over-year.